Market Tracker

12/14 5:15pm ET

Biogen Inc (NASDAQ:BIIB)

323.55
Delayed Data
As of 4:00pm ET
 -7.16 / -2.17%
Today’s Change
244.28
Today|||52-Week Range
348.84
+23.87%
Year-to-Date

Today’s Trading

Previous close330.71
Today’s open332.00
Day’s range321.11 - 332.00
Volume1,173,905
Average volume (3 months)1,255,146
Market cap$69.9B
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+9.07%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+9.37%
P/E ratio19.8
Price/Sales6.09
Price/Book5.88

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-3.70-1.72%
GILDGilead Sciences-1.72-2.26%
----
BIVVBioverativ Inc0.000.00%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateJanuary 31, 2018
EPS forecast (this quarter)$5.54
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts